drugset / Trial / NCT00288431
Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is designed to determine the safety, tolerability and maximum tolerated dose of Oral AP23573 in combination with Doxorubicin
Timeline
- Start
- 2006-02
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 60 mg/m2 | Intravenous |
| Subject | ridaforolimus | Small molecule | 10 mg | Oral |
| Subject | ridaforolimus | Small molecule | 30 mg | Oral |